ENERTIVA
RETATUTIDE 60mg
Product details are available publicly. Please log in to view pricing and place an order.
Login to View PriceTesting & COA
View History- Retatrutide is a next-generation multi receptor agonist targeting GLP-1 (glucagon like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This triple-pathway activation is designed to support a broader range of metabolic processes, including energy expenditure, appetite regulation, and glucose homeostasis.
- By incorporating glucagon receptor activity in addition to incretin signaling, retatrutideintroduces a differentiated mechanism that may influence both caloric intake and energy utilization. This expanded metabolic engagement positions it as a forward-looking option in structured metabolic and body composition–focused protocols.
- Produced under controlled, high-purity manufacturing standards, retatrutide offers consistency, stability, and reproducibility across batches—supporting clinical environments where precision and reliability are essential.
